Reboot Rx Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

AI

Industry

Estimated Revenue & Valuation

  • Reboot Rx's estimated annual revenue is currently $1.6M per year.(i)
  • Reboot Rx's estimated revenue per employee is $84,000

Employee Data

  • Reboot Rx has 19 Employees.(i)
  • Reboot Rx grew their employee count by 6% last year.

Reboot Rx's People

NameTitleEmail/Phone
1
Founder and CEOReveal Email/Phone
2
Founder and CEOReveal Email/Phone
3
Head Data ScienceReveal Email/Phone
4
Director Programs & OperationsReveal Email/Phone
5
Director Programs & OperationsReveal Email/Phone
6
Treasurer - Board DirectosReveal Email/Phone
7
Founding Board ChairReveal Email/Phone
8
Treasurer - Board DirectosReveal Email/Phone
9
Founding Board ChairReveal Email/Phone
10
Biomedical ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.7M61N/AN/AN/A
#2
$2.8M2938%N/AN/A
#3
$1.2M14-52%N/AN/A
#4
$3.5M313%N/AN/A
#5
$1190M5826-7%$31MN/A
#6
$25.9M168-2%$193.6MN/A
#7
$1.1M138%N/AN/A
#8
$0.5M7-22%N/AN/A
#9
$1.1M138%N/AN/A
#10
$10.9M780%N/AN/A
Add Company

What Is Reboot Rx?

Reboot Rx is the tech nonprofit startup dedicated to fast-tracking the development of affordable cancer treatments. Our strategy leverages repurposed generic drugs, AI technology, and innovative funding models.

keywords:N/A

N/A

Total Funding

19

Number of Employees

$1.6M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Reboot Rx News

2022-04-13 - Asus ROG Zephyrus G14 (2022) Review: Quick but Quirky

... small gaming laptops and either the AMD Radeon RX 6700S or RX 6800S, ... If you didn't have to reboot to switch from Hybrid to discrete...

2022-04-13 - TFSource News - MP-52+ Masterpiece Skywarp 2.0, Diaclone ...

TFSource News - MP-52+ Masterpiece Skywarp 2.0, Diaclone Reboot, ... RX-78GP01Fb Zephyranthes Full Burnern Master Grade 1/100 Scale | Gundam...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M196%$2.7M
#2
$0.6M190%$5M
#3
$3.7M19-30%N/A
#4
$3.1M19-32%N/A
#5
$2.7M19-14%N/A